Endothelin-1-dependent signaling pathways in the myocardium

Area of Science:

• Cardiovascular Physiology
• Molecular Cell Biology
• Biochemistry

Background:

• Endothelin-1 (ET-1) is a potent vasoactive peptide affecting cardiac myocyte contractility and growth.
• ET-1 exerts its effects by binding to transmembrane receptors, activating specific G protein signaling cascades.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the physiological effects of ET-1 on cardiac myocytes.
• To correlate ET-1-mediated signaling pathway activation with observed effects on cardiac myocyte contraction and growth.

Main Methods:

• Investigated the activation of G(q) and G(i) proteins by ET-1.
• Examined the downstream signaling events including phosphatidylinositol-4,5-bisphosphate hydrolysis, protein kinase C and Raf activation, and extracellular signal-regulated kinase (ERK) pathway stimulation.
• Assessed the counteraction of ET-1 on β-adrenoceptor-mediated cyclic AMP (cAMP) increases via G(i) activation.

Main Results:

• ET-1 binding activates G(q) proteins, leading to phosphatidylinositol-4,5-bisphosphate hydrolysis and subsequent activation of protein kinase C, Raf, and ERK.
• ET-1 also activates G(i) proteins, which inhibit β-adrenoceptor-stimulated increases in cAMP.
• These signaling events provide a mechanistic basis for ET-1's effects on cardiac myocyte contraction and growth.

Conclusions:

• ET-1 signaling pathways involving G(q)/ERK and G(i) are critical mediators of its physiological actions in cardiac myocytes.
• Understanding these pathways offers insights into cardiac function and potential therapeutic targets.